VYNE Therapeutics Inc.
2.73
-0.02 (-0.73%)
At close: Jan 15, 2025, 3:59 PM
2.76
1.10%
After-hours Jan 15, 2025, 04:00 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Cash & Equivalents 30.62M 30.91M 42.25M 57.56M 30.78M 49.51M 10.21M 4.03M 43.81M
Short-Term Investments 62.63M n/a n/a 1.03M 46.17M 86.74M 49.30M 26.88M n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a 2.98M 10.42M n/a
Other Long-Term Assets 1.51M 2.20M 3.51M 4.34M 73.00K 282.00K n/a 66.00K n/a
Receivables n/a 5.00M 7.58M 15.82M n/a n/a 786.00K n/a n/a
Inventory n/a 97.00K 7.29M 7.40M 1.36M n/a -2.98M n/a n/a
Other Current Assets 2.71M 2.37M 6.06M 4.59M 1.38M 6.50M 3.57M 632.00K 77.00K
Total Current Assets 95.96M 38.27M 63.19M 87.26M 78.33M 139.50M 63.86M 31.54M 43.88M
Property-Plant & Equipment 207.00K 282.00K 354.00K 2.14M 769.00K 146.00K 28.00K 27.00K n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 1.72M 2.48M 3.86M 6.48M 842.00K 428.00K 3.01M 10.51M n/a
Total Assets 97.69M 40.76M 67.05M 93.74M 79.17M 139.93M 66.87M 42.05M 43.88M
Account Payables 1.66M 2.39M 6.51M 4.78M 3.77M 3.29M 2.46M 1.53M 637.00K
Deferred Revenue n/a n/a n/a 15.81M 5.71M n/a 1.80M 1.80M n/a
Short-Term Debt 115.00K n/a 698.00K 1.51M 700.00K n/a n/a n/a n/a
Other Current Liabilities 5.76M 6.96M 11.20M 15.16M 6.19M 6.25M 3.56M 581.00K 133.00K
Total Current Liabilities 7.54M 9.35M 18.41M 21.45M 10.66M 9.54M 7.82M 3.90M 770.00K
Long-Term Debt 99.00K n/a n/a 34.03M n/a n/a n/a n/a n/a
Other Long-Term Liabilities 1.31M 211.00K n/a 769.00K n/a 7.00K 109.35M 59.06M 59.07M
Total Long-Term Liabilities 1.41M 211.00K n/a 34.80M 34.26M 7.00K 116.08M 67.59M 59.07M
Total Liabilities 8.95M 9.56M 18.41M 56.25M 10.66M 9.55M 123.90M 71.49M 59.84M
Total Debt 214.00K -349.00K 349.00K 34.78M 700.00K n/a n/a n/a n/a
Common Stock 1K 1.47M 5.00K 4.00K 3.00K 3.00K 1K 1K 1K
Retained Earnings -691.34M -662.74M -639.52M -566.20M -184.34M -110.64M -59.19M -30.11M -16.05M
Comprehensive Income 26.00K n/a n/a n/a 24.00K -96.00K -51.00K -26.00K -59.00M
Shareholders Equity 88.73M 31.20M 48.64M 37.49M 68.51M 130.38M -57.03M -29.44M -15.95M
Total Investments 62.63M n/a n/a 1.03M 46.17M 86.74M 52.27M 37.30M n/a